- Home
- CZNC vs ANGO Comparison
CZNC vs ANGO Comparison
Compare CZNC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZNC | ANGO |
|---|---|---|
| Founded | 1864 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.5M | 420.2M |
| IPO Year | 2009 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CZNC | ANGO |
|---|---|---|
| Price | $23.78 | $12.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $23.50 | $18.00 |
| AVG Volume (30 Days) | 68.2K | ★ 361.1K |
| Earning Date | 05-12-2026 | 04-02-2026 |
| Dividend Yield | ★ 4.87% | N/A |
| EPS Growth | 7.64 | ★ 81.92 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $3.11 | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | $1,181.50 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $18.16 | $8.36 |
| 52 Week High | $24.25 | $13.99 |
Technical Indicators
Market Signals| Indicator | CZNC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 66.48 | 60.42 |
| Support Level | $23.07 | $10.53 |
| Resistance Level | $23.96 | $13.37 |
| Average True Range (ATR) | 0.61 | 0.46 |
| MACD | 0.23 | 0.04 |
| Stochastic Oscillator | 80.56 | 63.47 |
Price Performance
Historical ComparisonAbout CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.